“Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study”, J of Skin, vol. 9, no. 6, p. s598, Nov. 2025, doi: 10.25251/2a8shm52.